UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
BJDX holding history
Bluejay Diagnostics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BJDX overviewAll 13F holders of BJDXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −124−100.0% | Sold out | Holders |
| Q1 2026 | 124 | $228 | <0.1% | +124 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −444−100.0% | Sold out | Holders |
| Q2 2025 | 444 | $764 | <0.1% | −368−45.3% | Reduced | Holders |
| Q1 2025 | 812 | $3.03K | <0.1% | −1,133−58.3% | Reduced | Holders |
| Q4 2024 | 1,945 | $9.47K | <0.1% | −59,503−96.8% | Reduced | Holders |
| Q3 2024 | 61,448 | $7.80K | <0.1% | +61,448 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −5,158−100.0% | Sold out | Holders |
| Q2 2023 | 5,158 | $1.36K | <0.1% | +5,158 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −10,061−100.0% | Sold out | Holders |
| Q4 2022 | 10,061 | $3.82K | <0.1% | −3,364−25.1% | Reduced | Holders |
| Q3 2022 | 13,425 | $10.0K | <0.1% | +13,174+5,248.6% | Added | Holders |
| Q2 2022 | 251 | $0 | 0.0% | −5,340−95.5% | Reduced | Holders |
| Q1 2022 | 5,591 | $6.00K | <0.1% | +577+11.5% | Added | Holders |
| Q4 2021 | 5,014 | $13.0K | <0.1% | +5,014 | New | Holders |